Le Lézard
Classified in: Science and technology
Subject: Personnel

Own Company Announces the Appointment of Kevin Delane as Chief Operating Officer


Own Company, the industry leader for SaaS data protection and activation, today announced that Kevin Delane has been appointed Chief Operating Officer. Kevin joined Own in 2023 as Chief Revenue Officer, and quickly established several key strategic relationships and launched a new Channel Partner Program. In his new role, Kevin will lead Own Company's high performance Go-to-Market team, aligning sales and marketing under one organization, harmonizing these functions to leverage the massive opportunity in the SaaS data market.

"As we drive forward in our next chapter of innovation and growth, I am thrilled to expand Kevin's scope to Chief Operating Officer. In just a year, Kevin has proven himself as a transformative business leader, delivering measurable results and inspiring our customers and team with his passion and collaborative approach," said Sam Gutmann, Chief Executive Officer at Own. "Kevin brings more than 30 years of experience in data storage, global business operations, strategy, and scaling to this role, and has been an invaluable asset to our team over the past year. I am confident that he will make a tremendous impact on our long-term success, and that of our customers, in his new role as COO."

Before joining Own, Kevin served as Chief Revenue Officer at Cohesity, where he oversaw all aspects of business development and the customer life cycle, including global sales and sales operations, go-to-market, strategic alliances, partner management, and systems engineering. Prior to this, Kevin was Vice President of Worldwide Sales at Pure Storage for over seven years, where he grew revenue from $35M to $1.7B. He also spent over 18 years at Dell EMC in senior sales leadership roles.

"The average cost of a data incident is almost $5 million, and the risk of inaction threatens your company's reputation, business continuity and bottom line. At Own, we empower our customers to ensure the availability, compliance, and security of mission-critical data, unlocking new ways for our customers to use that data for a competitive advantage," said Kevin Delane, Chief Operations Officer at Own. "As COO, I am excited to turn my focus to implementing strategies that enable Own to meet the data protection and activation needs of all SaaS data users everywhere."

About Own

Own is the industry leader in SaaS data protection and activation, trusted by thousands of organizations to ensure the availability, security and compliance of mission-critical data, while unlocking new ways to gain deeper insights faster. By partnering with some of the world's largest SaaS ecosystems such as Salesforce, ServiceNow and Microsoft Dynamics 365, Own enables customers around the world to truly own their data and transform their business.

It's their platform. It's your data. Own it.

Learn more at owndata.com.

To learn more about becoming an Own Company partner, visit: owndata.com/partners


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: